Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / ABACUS FCF INNOV
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
2.54M
-
Shares change
-
-165K
-
Total reported value, excl. options
-
$59.6M
-
Value change
-
-$3.86M
-
Number of buys
-
3
-
Number of sells
-
-14
-
Price
-
$23.48
Significant Holders of ABACUS FCF ETF TR - ABACUS FCF INNOV (ABOT) as of Q1 2023
18 filings reported holding ABOT - ABACUS FCF ETF TR - ABACUS FCF INNOV as of Q1 2023.
ABACUS FCF ETF TR - ABACUS FCF INNOV (ABOT) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.54M shares
.
Largest 10 shareholders include ENVESTNET ASSET MANAGEMENT INC (1.57M shares), MML INVESTORS SERVICES, LLC (484K shares), CONCOURSE FINANCIAL GROUP SECURITIES, INC. (302K shares), Geneos Wealth Management Inc. (39.7K shares), Atria Wealth Solutions, Inc. (35.6K shares), ADVISOR GROUP HOLDINGS, INC. (25.8K shares), PARK AVENUE SECURITIES LLC (25.5K shares), Kestra Advisory Services, LLC (16.9K shares), Global Retirement Partners, LLC (14.3K shares), and Donoghue Forlines LLC (14.3K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.